(Q47157890)

9 January 2018

title

Accounting for patient heterogeneity in phase II clinical trials (English)

1 reference

9 January 2018

main subject

phase II clinical trial

0 references

1 reference

1 reference

4

Elihu H Estey

1 reference

9 January 2018

author name string

J Kyle Wathen

series ordinal

1

1 reference

9 January 2018

Peter F Thall

series ordinal

2

1 reference

9 January 2018

John D Cook

series ordinal

3

1 reference

9 January 2018

language of work or name

English

0 references

publication date

1 July 2008

1 reference

9 January 2018

published in

Statistics in Medicine

1 reference

9 January 2018

volume

27

1 reference

9 January 2018

issue

15

1 reference

9 January 2018

page(s)

2802-2815

1 reference

9 January 2018

Optimal two-stage designs for phase II clinical trials

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5708894

A geometric approach to comparing treatments for rapidly fatal diseases.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5708894

Monitoring event times in early phase clinical trials: some practical issues.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5708894

One- and two-stage designs for stratified phase II clinical trials

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5708894

Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5708894

Bayesian interim analysis of phase II cancer clinical trials.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5708894

Practical Bayesian guidelines for phase IIB clinical trials.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5708894

A Simplex Method for Function Minimization

15 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FSIM.3109

One-sample multiple testing procedure for phase II clinical trials

21 January 2018

1 reference

12 December 2020

Comparing an experimental agent to a standard agent: relative merits of a one-arm or randomized two-arm Phase II design

1 reference

12 December 2020

Optimal three-stage designs for phase II cancer clinical trials

1 reference

12 December 2020

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

12 December 2020

Identifiers

DOI

10.1002/SIM.3109

1 reference

9 January 2018

PMC publication ID

5708894

1 reference

9 January 2018

PubMed publication ID

17948869

1 reference

9 January 2018